Liver diseases diagnosis

Screening for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status.

    Related Conference of Liver diseases diagnosis

    August 6-7, 2018

    14th Annual Congress on Gastroenterology & Hepatology

    Hyatt Regency Osaka, Japan
    August 20-21, 2018

    13th Euro-Global Gastroenterology Conference

    Rome, Italy
    September 7-8, 2018

    18th World Gastroenterologists Summit

    Auckland, New Zealand
    September 17-18, 2018

    3rd International Conference on Hepatobiliary & Pancreatic Disorders

    | Philadelphia, Pennsylvania, USA
    September 21-22, 2018

    6th International Conference on Hepatology

    Osaka, Japan
    October 15-16, 2018

    3rd World Liver Congress

    Abu Dhabi, UAE
    October 29-30, 2018

    4th World Congress on Digestive & Metabolic Diseases

    | San Francisco, California, USA
    November 07-08, 2018

    World Summit on Liver Cirrhosis and Hepatitis

    Singapore
    November 08-09, 2018

    15th World Congress on Gastroenterology & Therapeutics

    Auckland, Newzealand
    March 04-06, 2019

    20th World Congress on Gastroenterology

    Berlin, Germany
    June 17-18, 2019

    World Liver Conference 2019

    Columbus, Ohio, U.S.A
    August 13-14, 2019 Auckland,New Zealand

    21st Asia Pacific Diabetes Conference

    Liver diseases diagnosis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in